U.S. Membrane Bioreactor Market Forecast to Reach USD 1,341.08 Million by 2032 at a CAGR of 6.31% During 2026–2032

The U.S. Membrane Bioreactor (MBR) Market was valued at USD 860.20 Million in 2025 and is projected to grow from USD 928.89 Million in 2026 to USD 1,341.08 Million by 2032, expanding at a CAGR of 6.31% during 2026–2032. The market is witnessing sustained growth as municipalities and industrial operators increasingly adopt advanced wastewater treatment technologies to address water scarcity, comply with stringent discharge regulations, and support long-term water reuse objectives.

The transition of membrane bioreactor technology from a niche wastewater treatment solution to a mainstream component of municipal and industrial water management strategies is becoming increasingly evident. Regulatory initiatives such as the National Water Reuse Action Plan and multiple state-level clean water programs are encouraging utilities to invest in advanced treatment systems capable of producing reuse-grade effluent. Furthermore, water-stressed regions across the United States are increasingly prioritizing wastewater recycling and reclamation projects, strengthening demand for membrane-based treatment infrastructure.

Moreover, the market is experiencing increasing momentum toward energy-efficient membrane technologies. Utilities and industrial operators are focusing on reducing operational expenditures and carbon emissions through the adoption of advanced low-pressure membrane configurations with enhanced fouling resistance and improved permeability. Recent innovations in hollow-fiber, flat-sheet, and ceramic membrane technologies are supporting higher treatment efficiency while lowering lifecycle operating costs, positioning next-generation MBR systems for broader deployment across municipal reuse facilities, industrial wastewater treatment plants, and decentralized treatment applications, further states as recent report “U.S. Membrane Bioreactor Market Analysis, 2026”.

U.S. Membrane Bioreactor Market Highlights

The U.S. Membrane Bioreactor Market is projected to grow from USD 928.89 Million in 2026 to USD 1,341.08 Million by 2032, registering a CAGR of 6.31% during the forecast period.
Submerged MBR Systems (SMBR) dominate the system configuration segment with an 81% market share, supported by lower energy consumption, reduced operating costs, and widespread deployment across municipal and industrial wastewater treatment facilities.
Ultrafiltration (UF)-based MBR systems lead the technology integration segment, accounting for approximately 68% of the market, owing to superior contaminant removal performance and suitability for water reuse applications.
The Southern United States holds the largest regional share at approximately 34%, driven by rapid population growth, increasing water stress, and significant investments in wastewater treatment and water reclamation infrastructure.
The market remains moderately consolidated, with the top five players collectively accounting for around 70% of total market revenue, reflecting strong leadership in membrane technology, large-scale project execution, and municipal wastewater treatment deployments.